The effects that we saw over the initial six-month study seem to be maintained over one year.

In 2003, we showed that a new medication that works by a novel system was effective in the moderate to severe stages of Alzheimer's disease.

I'll have to study a lot harder and take better notes.

The problem with the study is that big-box retailers and online retailers are not within the area studied. Overall, record sales are up more than 8 percent year-to-year (but) sales at independent record stores are down more than 4 percent.

The initial results of this phase I/II study in RA are very encouraging. We are looking forward to the ongoing development of HuMax-CD20 in RA.

This was an important study to do. What it points out, apart from the negative results, is the importance of doing such randomized trials so that we know whether a particular treatment is effective or not.